Stocks of Standard BioTools Inc (NASDAQ:LAB) traded higher last session on Wall Street, up 2.46% to $2.91.
LAB stock price is now 14.25% away from the 50-day moving average and 21.69% away from the 200-day moving average. The market capitalization of the company currently stands at $1.11B.
With the price target of $3.25, Jefferies recently initiated with Buy rating for Standard BioTools Inc (NASDAQ: LAB). On July 12, 2023, KeyBanc Capital Markets recently initiated its ‘Overweight’ rating on the stock quoting a target price of $4
In other news, Casdin Partners Master Fund, L, Director bought 1,403 shares of the company’s stock on Mar 05 ’24. The stock was bought for $3,669 at an average price of $2.62. Upon completion of the transaction, the Director now directly owns 11,497,928 shares in the company, valued at $33.46 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 04 ’24, Director Casdin Partners Master Fund, L bought 250,000 shares of the business’s stock. A total of $642,500 was incurred on buying the stock at an average price of $2.57. This leaves the insider owning 11,496,525 shares of the company worth $33.45 million. A total of 2.56% of the company’s stock is owned by insiders.
During the past 12 months, Standard BioTools Inc has had a low of $1.46 and a high of $3.16. As of last week, the company has a debt-to-equity ratio of 0.60, a current ratio of 1.45, and a quick ratio of 1.26. The fifty day moving average price for LAB is $2.5592 and a two-hundred day moving average price translates $2.3960 for the stock.
The latest earnings results from Standard BioTools Inc (NASDAQ: LAB) was released for Dec, 2021. According to the Diagnostics & Research Company, earnings per share came in at $0, inline with analysts’ expectations of $0. This compares to -$0.25 EPS in the same period last year. The net profit margin was -70.21% and return on equity was -37.99% for LAB. The company reported revenue of $28.19 million for the quarter, compared to $27.02 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.32 percent.
